return to results page

VAERS ID: 1000434

AGE: 29| SEX: F|State: FR

Description

headache; Asthenia/adynamia; myalgia; chills; malaise in general; Asthenia/fatigue; arthralgia in the elbows; Decreased strength and sensation of the left pelvic limb; Decreased strength and sensation of the left pelvic limb; This is a spontaneous report from a non-contactable other healthcare professional (HCP). A 29-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ3002, expiration date 30Apr2021) intramuscular in the left arm on 14Jan2021 at a single dose for COVID-19 immunization. Medical history included allergies. Concomitant medications were not reported. On 14Jan2021, the patient experienced headache, asthenia/fatigue, adynamia, chills, myalgia- timeframe between vaccination and starting of symptoms was noted as 8 hrs. The patient also experienced arthralgia, and decreased strength and sensation of the left pelvic limb on 14Jan2021. The patient was hospitalized due to the events on Jan2021. The clinical course noted that the condition began with chills, malaise in general, fatigue, so she decided to fall asleep for 2 hours and 30 minutes, upon waking she referred to arthralgia in the elbows, later she loses strength in the left pelvic limb. She was evaluated and hospitalized to carry out laboratories and cabinet. The outcome of the events was unknown. Events supposedly attributable to vaccination or immunization (ESAVI) type was noted as serious. No follow-up attempts are possible. No further information is expected.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Symptoms

Arthralgia, Hypoaesthesia, Asthenia, Malaise, Chills, Muscular weakness, Fatigue, Myalgia, Headache

Vaccines

VAX DATE: 13 January 2021 | ONSET DATE: 13 January 2021 | DAYS TO ONSET: 0
Vaccine TypeManufacturerVaccine NameDoseRouteSiteLot
  • COVID19
  • PFIZERBIONTECH
  • COVID19 (COVID19 (PFIZER-BIONTECH))
  • 1
  • OT
  • LA
  • EJ3002

RECVDATE:
03 February 2021
CAGE_YR:
CAGE_MO:
RPT_DATE:
DIED:
DATEDIED:
L_THREAT:
ER_VISIT:
HOSPITAL:
Y
HOSPDAYS:
X_STAY:
DISABLE:
RECOVD:
U
LAB_DATA:
V_ADMINBY:
OTH
OTHER_MEDS:
CUR_ILL:
HISTORY:
Medical History/Concurrent Conditions: Allergy
PRIOR_VAX:
SPLTTYPE:
MXPFIZER INC2021069216
FORM_VERS:
2
TODAYS_DATE:
01 February 2021
BIRTH_DEFECT:
OFC_VISIT:
ER_ED_VISIT:
ALLERGIES:
V_FUNDBY:
return to results page

Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.

AND PLEASE read the FAQ first.

OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.